Abstract: The present invention relates to novel cosmetic and therapeutic uses of one or more compounds of the general formula (1) as described herein. Furthermore, the present invention relates to compositions (products or, respectively, formulations), in particular for topical administration, preferably cosmetic or pharmaceutical compositions, comprising or consisting of compound(s) of formula (1) and one or more cosmetically and/or pharmaceutically acceptable carriers. The present invention also relates to novel uses of such compositions according to the invention.

Abstract: The present invention belongs to the fields of pharmaceuticals and cosmetics, and concerns on the one hand a medicament for the inhibition of and refers also on the cosmetic, non-therapeutic use for the treatment of hyperpigmentation, particularly induced by sun light radiation, preferably induced by visible light radiation.

Abstract: Suggested is a cosmetic blend, comprising or consisting of (a) at least one TRPV1 and/or TRPV3 modulator and (b1) at least one 1,2-alkandiol having 5 to 12 carbon atoms and/or (b2) at least one polyol having 3 to 12 carbon atoms and 3 to 6 hydroxyl groups.

Abstract: The present invention belongs to the fields of pharmaceuticals and cosmetics, and concerns on the one hand a medicament for the inhibition of and refers also on the cosmetic, non-therapeutic use for the treatment of hyperpigmentation, particularly induced by sun light radiation, preferably induced by visible light radiation.

Abstract: The present invention relates to novel cosmetic and therapeutic uses of one or more compounds of the general formula (1) as described herein. Furthermore, the present invention relates to compositions (products or, respectively, formulations), in particular for topical administration, preferably cosmetic or pharmaceutical compositions, comprising or consisting of compound(s) of formula (1) and one or more cosmetically and/or pharmaceutically acceptable carriers. The present invention also relates to novel uses of such N compositions according to the invention.

Abstract: The present invention belongs to the fields of pharmaceuticals and cosmetics, and concerns on the one hand a medicament for the inhibition of and refers also on the cosmetic, non-therapeutic use for the treatment of hyperpigmentation, particularly induced by sun light radiation, preferably induced by visible light radiation.

Abstract: The invention relates to a preparation containing at least one compound of formula (I), providing that R1 is H or CH3 and R2 is II or COOII, or salts thereof, to be used as a drug for preventing and/or treating signs of degeneration and ageing of the skin which are not, or not exclusively, caused by the effect of light.

Abstract: The invention relates to emulsions containing (a) at least one UV sunscreen factor, (b) at least one compound of formula (I) where R1 is II or CII3 and R2 is II or COOII or salts thereof, (c) at least one emulsifier, and optionally (d1) a carrier and/or (d2) an oil body, providing that the emulsions have a droplet size at which the D50 value ranges from 0.1 to 100 ?m.

Abstract: Suggested is a cosmetic blend, comprising or consisting of (a) at least one TRPV1 and/or TRPV3 modulator and (b1) at least one 1,2-alkandiol having 5 to 12 carbon atoms and/or (b2) at least one polyol having 3 to 12 carbon atoms and 3 to 6 hydroxyl groups.

Abstract: The present invention belongs to the fields of pharmaceuticals and cosmetics, and concerns on the one hand a medicament for the inhibition of and refers also on the cosmetic, non-therapeutic use for the treatment of hyperpigmentation, particularly induced by sun light radiation, preferably induced by visible light radiation.

Abstract: The present invention belongs to the fields of pharmaceuticals and cosmetics, and concerns on the one hand a medicament for the inhibition of and refers also on the cosmetic, non-therapeutic use for the treatment of hyperpigmentation, particularly induced by sun light radiation, preferably induced by visible light radiation.

Abstract: The invention relates to a preparation containing at least one compound of formula (I), providing that R1 is H or CH3 and R2 is II or COOII, or salts thereof, to be used as a drug for preventing and/or treating signs of degeneration and ageing of the skin which are not, or not exclusively, caused by the effect of light.

Abstract: The invention relates to emulsions containing (a) at least one UV sunscreen factor, (b) at least one compound of formula (I) where R1 is II or CII3 and R2 is II or COOII or salts thereof, (c) at least one emulsifier, and optionally (d1) a carrier and/or (d2) an oil body, providing that the emulsions have a droplet size at which the D50 value ranges from 0.1 to 100 ?m.

Abstract: Proposed is a drug containing (a) at least one compound of Formula (I) provided that R1 denotes H or CH3 and R2 denotes H or COOH, or salts thereof, and (b) at least one UV protection factor for the inhibition of MMP-1 expression induced by UV radiation.

Abstract: The invention concerns a blackberry leaf extract and its uses, in particular to slow down skin aging, to treat the oral and pharyngeal cavity, and there in particular to prevent and slow down periodontitis and the excessive degradation of the periodontal connective tissue as well as damage to the teeth caused by matrix metalloproteinases.

Abstract: Suggested is a skin or hair whitening mixture, comprising (a) resorcinol derivatives of formula (I) in which R stands for an alkyl radical having 3 to 10 carbon atoms or an optionally substituted alkylphenyl radical having 8 to 16 carbon atoms, and (b) bisabolol, and optionally (c) alkandiols having 3 to 10 carbon atoms.

Abstract: Novel uses of compounds of the Formula 1 or mixtures of substances that contain one more compounds of the Formula 1, are described. The said compounds are suitable as agents against skin and hair browning, for combating age spots and for the inhibition of the undesired browning of foods.

Abstract: Proposed is a drug containing (a) at least one compound of Formula (I) provided that R1 denotes H or CH3 and R2 denotes H or COOH, or salts thereof, and (b) at least one UV protection factor for the inhibition of MMP-1 expression induced by UV radiation.

Abstract: The present invention relates to the cosmetic, dermatological or therapeutic use of certain cyclohexyl carbamate compounds of formula (I) given below, preferably as skin and/or hair lightening (whitening) actives. The invention further relates to compositions and cosmetic, dermatological or therapeutic products comprising one or more compounds of formula (I) suitable for lightening human skin and/or hair and corresponding methods.

Abstract: The present invention relates to the cosmetic, dermatological or pharmaceutical (therapeutic) use of compounds of formula (I) or a cosmetically acceptable salt of a compound of formula (I) or a mixture containing two or more of these compounds or the salts thereof wherein R1 denotes hydrogen or an organic radical having 1 to 14 carbon atoms, R2 denotes an organic radical having 1 to 14 carbon atoms, and wherein optionally R1 and R2 are covalently bonded to one another, preferably so that a 3 to 8 membered ring is formed, for the lightening of skin and/or hair. The invention further relates to compositions and cosmetic, dermatological or pharmaceutical preparations (compositions) comprising one or more compounds of formula (I) suitable for lightening human skin and/or hair and corresponding methods.